Clinical Trial Update: A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Vedolizumab in children and teenagers with ulcerative colitis or Crohn's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Ulcerative Colitis, Crohn's Disease | Phase 3 | Status: RECRUITING